Prevention of EGF-modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition

Elke Genersch, Douglas W. Schneider, Gerhard Sauer, Kashayarsha Khazaie, Detlef Schuppan, Rosemarie B. Lichtner

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


The adhesion of tumor cells to various extracellular matrix (ECM) proteins is influenced by epidermal growth factor (EGF). Maximal effects are obtained at low EGF concentrations, at which mostly the cytoskeleton- associated high-affinity EGF receptors (EGFRs) are saturated. Tumor cells expressing EGFR either endogenously (MDA MB 231, MTLn3) or, for the human EGFR, ectopically (MTC HERI/I) in intermediate amounts exhibited, upon EGF addition, increased cellular adhesion to various ECM proteins, such as fibronectin, collagens and vitronectin. In contrast, human A431 and MDA MB 468 cells, over-expressing EGFR, demonstrated reduced attachment in similar experimental conditions. Both increased as well as reduced EGF-dependent adhesion could be blocked using either ligand-blocking monoclonal antibody 14EI or the potent EGFR tyrosine kinase inhibitor PD 153035. Our data indicate that signals downstream of EGFR activation are responsible for the opposing effects of EGF on cellular adhesion since both can be prevented by EGFR inhibition. Thus, the integration of EGFR-and integrin-dependent signals can be different in carcinoma cell lines and might be influenced by EGFR numbers.

Original languageEnglish (US)
Pages (from-to)205-209
Number of pages5
JournalInternational Journal of Cancer
Issue number2
StatePublished - Jan 19 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Prevention of EGF-modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition'. Together they form a unique fingerprint.

Cite this